Advancement of Copaxone—regulatory. . . 10% 70% 7.0%
Advancement of Copaxone—development . . 10% 70% 7.0%
I find this "assessment" somewhat bothering in that they are not all that bullish on their own efforts on m-Copaxone and where things stand today. Anyone else draw the same inference?